ABOUT  |  NEWS  |  PRODUCTS  |  TECHNOLOGY  |  INVESTOR RELATIONS  |  CAREER  |  PATIENTS

NEWS

Nov. 21, 2011

MOLOGEN attains the goals of the renal cancer study with MGN1601 ahead of schedule

 

 the press release

Nov. 18, 2011

MOLOGEN AG appoints Dr. Stefan M. Manth to the scientific advisory board


 the press release

NEWSLETTER

To receive our press releases please

 click here

PRODUCTS

More information about our products

  CELL-BASED
  GENE THERAPY

  CANCER THERAPY
  WITH dSLIM

TECHNOLOGY

More information about our technologies

  MIDGE

  MIDGE-Th1

  dSLIM